Antiparasitic Drugs Market Poised for Steady Growth in the Future, 2021 to 2027
The Global Antiparasitic Drugs Market, by Drug Class (Anthelmintics (Benzimidazoles, Pyrantel, Niclosamide, Praziquantel, and Others), Antiprotozoals (Antimalarial Drugs-Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and sulfones, Others), and Other Antiprotozoal Agents), and Others (Pediculocides and miticulocides) (Lindane, Malathion, Pyrethrins, and Others), by Route of Administration (Oral, Injectable, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was esteemed at US$ 7,227.9 million of every 2019 and is relied upon to show a CAGR of 5.2% during the estimate time frame (2020-2027), as featured in another report distributed by Coherent Market Insights.
The increasing launches of antiparasitic drugs is required to impel development of the worldwide antiparasitic drugs market during the forecast time frame. For example, in August 2019, Teva Pharmaceuticals dispatched an AB-evaluated conventional variant of Galderma’s Soolantra (ivermectin) cream showed for the treatment of provocative injuries of rosacea. In addition, in January 2018, Perrigo Company plc. received provisional U.S. Food and Drug Administration endorsement to dispatch nonexclusive rendition of the Soolantra (ivermectin)
Activities taken by government and non-profit associations to make mindfulness identified with the parasitic infections among the populace and giving appropriate treatment is adding to the market development. Also, these association are zeroing in on setting up new innovative work habitats in high danger tropical and subtropical areas. For example, in June 2018, the University of California San Diego dispatched another Center for Anti-Parasitic Drug Discovery and Development at San Diego which incorporates 15 exploration and clinical offices.
Besides, the raising occurrence of parasitic contaminations, for example, Chagas Disease is expected to drive the market development. As indicated by the World Health Organization (WHO) assessment, in March 2020, around 6-7 million individuals across the globe are expected to be determined to have Chagas Disease, a parasitic contamination caused due the Trypansosoma cruzi parasite. The WHO likewise expressed that dominant part of the influenced populace is from the Latin America locale. The Chagas Disease can be all around treated with benznidazole and nifurtimox. Hence, the growing prevelence of the Chagas illness is expected to drive interest for these medications in the region.
Key Takeaways of the Global Antiparasitic Drugs Market:
The worldwide antiparasitic drugs market is required to display a CAGR of 5.2% during the forecast time frame (2020–2027) inferable from activities taken by different exploration associations to create novel medications for treating parasitic infections. For example, on April 23, 2019 Lupin Research Inc. started stage 3 investigation to assess the viability, and wellbeing of a solitary, oral portion of Solosec containing 2 grams of secnidazole in female patients with trichomoniasis. The investigation is assessed to be finished in 2020.
Among drug class, antiprotozoals is expected to hold dominant position in the overall industry in antiparasitic drugs market inferable from the developing interest for antimalarial drugs in key districts like India and other South-east Asian nations, just as high predominance of jungle fever in these nations is expected to drive development of antiparasitic drugs market. For example, as per the World Health Organization in 2017, around 3 million instances of intestinal sickness were analyzed in India. Besides, the WHO expressed that in 2019, India represented 21% of the total deaths in South-east Asia district.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3782
Antiparasitic Drugs Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, Roche Inc., Arbor Pharmaceuticals Inc., Sanofi, AstraZeneca plc., and Alkem Laboratories Limited
Main points in Antiparasitic Drugs Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Antiparasitic Drugs Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Antiparasitic Drugs Industry Impact
Chapter 2 Global Antiparasitic Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Antiparasitic Drugs (Volume and Value) by Type
2.3 Global Antiparasitic Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Antiparasitic Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Antiparasitic Drugs Market Analysis
Chapter 6 East Asia Antiparasitic Drugs Market Analysis
Chapter 7 Europe Antiparasitic Drugs Market Analysis
Chapter 8 South Asia Antiparasitic Drugs Market Analysis
Chapter 9 Southeast Asia Antiparasitic Drugs Market Analysis
Chapter 10 Middle East Antiparasitic Drugs Market Analysis
Chapter 11 Africa Antiparasitic Drugs Market Analysis
Chapter 12 Oceania Antiparasitic Drugs Market Analysis
Chapter 13 South America Antiparasitic Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Antiparasitic Drugs Business
Chapter 15 Global Antiparasitic Drugs Market Forecast (2021-2027)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
- CDN Newswire